A circuitous way to target p53

被引：6
|
作者：
Seton-Rogers, Sarah
机构：
来源：
NATURE REVIEWS CANCER | 2015年 / 15卷 / 06期
关键词：
D O I：
10.1038/nrc3962
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Liuet al. show that the mushroom-derived toxin α-amanitin, conjugated to antibodies against a tumour-specific biomarker, might be effective therapeutically (with minimal toxicity) for tumours that have hemizygous deletions of TP53 that also encompass POLR2A.
引用
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [1] A circuitous way to target p53
    Sarah Seton-Rogers
    Nature Reviews Cancer, 2015, 15 : 318 - 319
  • [2] A Neat target of p53
    Eytan Zlotorynski
    Nature Reviews Molecular Cell Biology, 2017, 18 : 532 - 532
  • [3] p53 as a therapeutic target
    Staples, O. D.
    Steele, R. J. C.
    Lain, S.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2008, 6 (04): : 240 - 243
  • [4] Role of p53 Serine 46 in p53 Target Gene Regulation
    Smeenk, Leonie
    van Heeringen, Simon J.
    Koeppel, Max
    Gilbert, Bianca
    Janssen-Megens, Eva
    Stunnenberg, Hendrik G.
    Lohrum, Marion
    PLOS ONE, 2011, 6 (03):
  • [5] PML is a direct p53 target that modulates p53 effector functions
    de Stanchina, E
    Querido, E
    Narita, M
    Davuluri, RV
    Pandolfi, PP
    Ferbeyre, G
    Lowe, SW
    MOLECULAR CELL, 2004, 13 (04) : 523 - 535
  • [6] p53 as a target in myeloproliferative neoplasms
    Lu, Min
    Hoffman, Ronald
    ONCOTARGET, 2012, 3 (10) : 1052 - 1053
  • [7] p53 as a target for the treatment of cancer
    Duffy, Michael J.
    Synnott, Naoise C.
    McGowan, Patricia M.
    Crown, John
    O'Connor, Darran
    Gallagher, William M.
    CANCER TREATMENT REVIEWS, 2014, 40 (10) : 1153 - 1160
  • [8] p53 isoform Δ113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish
    Chen, Jun
    Ng, Sok Meng
    Chang, Changqing
    Zhang, Zhenhai
    Bourdon, Jean-Christophe
    Lane, David P.
    Peng, Jinrong
    GENES & DEVELOPMENT, 2009, 23 (03) : 278 - 290
  • [9] Target p53 functionally null ovarian cancers for p53 gene replacement: Not all p53 mutations are created equal!
    Buller, RE
    Shahin, MS
    Hughes, JH
    Sorosky, JI
    Anderson, B
    Sood, AK
    CANCER GENE THERAPY, 1999, 6 (06) : S4 - S4
  • [10] HETEROGENEITY OF TRANSCRIPTIONAL ACTIVITY OF MUTANT P53 PROTEINS AND P53 DNA TARGET SEQUENCES
    CHEN, JY
    FUNK, WD
    WRIGHT, WE
    SHAY, JW
    MINNA, JD
    ONCOGENE, 1993, 8 (08) : 2159 - 2166
12345